Literature DB >> 17953286

Chronic daily headache and medication overuse headache: clinical read-outs and rehabilitation procedures.

S de Filippis1, E Salvatori, I Farinelli, G Coloprisco, P Martelletti.   

Abstract

The impact of headache on the person and society represents a public health issue. Recently a study evaluated 51% of headache's prevalence in Europe, of which 14% is affected by migraine. Besides, 4% of adult population is affected by chronic forms, which constitute therefore an even more relevant problem in terms of health and social policies. The International Classification of Headache Disorders, II version (ICHD-II) recognises 24 types of chronic headache and states primary episodic headaches as chronic when attacks appear for more than 15 days per month, for at least three months. Headache given by drugs overuse, defined by ICDH-II in 2004 (and revised in 2005) as Medication Overuse Headache (MOH), is associated with overuse of a combination of analgesics, barbiturates, opioids, ergot alkaloids, aspirin, AINS, caffeine and triptans. Patients affected by MOH present a reduced work performance and a significant alteration in the quality of life. Furthermore, some psychological and behavioural states seem particularly important in promoting and sustaining drug abuse. The management and rehabilitation of patients affected by CDH, abusing symptomatic drugs, consists in the withdrawal and/or gradual reduction of their assumption, because of tolerance and addiction possibilities.

Entities:  

Mesh:

Year:  2007        PMID: 17953286

Source DB:  PubMed          Journal:  Clin Ter        ISSN: 0009-9074


  3 in total

1.  Mental turmoil, suicide risk, illness perception, and temperament, and their impact on quality of life in chronic daily headache.

Authors:  Sergio De Filippis; Denise Erbuto; Federica Gentili; Marco Innamorati; David Lester; Roberto Tatarelli; Paolo Martelletti; Maurizio Pompili
Journal:  J Headache Pain       Date:  2008-10-25       Impact factor: 7.277

2.  Psychiatric comorbidity and suicide risk in patients with chronic migraine.

Authors:  Maurizio Pompili; Gianluca Serafini; Daniela Di Cosimo; Giovanni Dominici; Marco Innamorati; David Lester; Alberto Forte; Nicoletta Girardi; Sergio De Filippis; Roberto Tatarelli; Paolo Martelletti
Journal:  Neuropsychiatr Dis Treat       Date:  2010-04-07       Impact factor: 2.570

Review 3.  Genetics of migraine and pharmacogenomics: some considerations.

Authors:  Maria Piane; Patrizia Lulli; Ivano Farinelli; Simona Simeoni; Sergio De Filippis; Francesca Romana Patacchioli; Paolo Martelletti
Journal:  J Headache Pain       Date:  2007-12-05       Impact factor: 7.277

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.